If .10 is all this news is worth, how will we ever even make it into the $3 range before year end? I have been holding my shares for a number of years and am disappointed in the Market's acceptance of IMUC. GLTA
because it's only interim data. as i learned in ZIOP in the interim review they continued the trial and when final results came out i believe the phrase "wasn't even close" was used. so many people thought their drug would be effective.
granted, this is different. will all the modeling i've seen, reasonable projections and whatnot, if you take the time to really look at the data, it should be trading more than 18cents up. but perhaps people are gun shy. i know i am. the science behind this technology intrigues me and i see it changing medicine.... if it works. i have a small stake for now. but i keep telling myself.. its only interim data. im crossing my fingers its not another ZIOP.
no one ever doubted that this would not be the result at this stage of the trial if one understands the science it was very obvious that safety would not be an issue here even AF doesnt really understand the and potential here